Purchase Order W81K0220P0171
- Not listed
- This is a firm fixed-price purchase order awarded by the U.S. Department of Defense Medical Command (MEDCOM) to Sebia, Inc., a global provider of automated electrophoresis technologies and clinical laboratory services. The $1,392,082.60 contract provides immunochemistry testing kits to support diagnostic testing programs at VA medical facilities and military treatment centers nationwide. The contract has a Total Small Business set-aside designation and a performance period through September...
- This federal contract award is for $156,354 and was issued by the Defense Health Agency to Sebia, Inc., a global leader in automated electrophoresis technologies. The contract is for the provision of hemoglobin reagents, calibrators, quality controls, and consumables for the government-owned Sebia Octa Capillary Zone Electrophoresis Analyzers located at Madigan Army Medical Center. The contract also includes technical support, parts, maintenance, and repair services for the analyzers. This...
- This is a federal contract award made by the U.S. Army Medical Command (MEDCOM) to Sebia, Inc., a global leader in automated electrophoresis technologies. The $192,554.30 firm fixed-price delivery order contract is for the provision of Immunochemistry equipment and reagents to the San Antonio Military Medical Center at Fort Sam Houston, Texas. The contract has no set-aside designation and was awarded on September 29, 2015, with a completion date of September 30, 2016. Sebia, Inc. is based in...
- <p>Sebia, Inc. was awarded a $101,089.38 firm fixed price delivery order to provide electrophoresis supplies and reagents to the Triple Army Medical Center in Hawaii through September 30, 2021. The contract was awarded by the Department of the Army Medical Command on October 1, 2020 without a set-aside designation. Under this delivery order, Sebia will supply the requested electrophoresis products and services to support the Triple Army Medical Center's medical laboratory testing programs.</p>
- This firm-fixed-price delivery order was awarded to Sebia, Inc. by the Defense Health Agency (DHA) under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule contract. The $375,000.00 contract provides reagents and peripherals to support laboratory diagnostic testing services, including serum protein electrophoresis, urine protein electrophoresis, hemoglobin electrophoresis, and other specialized clinical pathology analyses. Sebia, Inc. is a global leader in automated...
- This is a $125,000.00 firm fixed price delivery order contract awarded by the Defense Health Agency to Sebia, Inc., a for-profit medical equipment and testing services provider. The contract is for the provision of reagents, lab supplies, and a Hydrasys 2 blood and urine testing system, along with related laboratory testing services. The contract is not set aside and draws from Sebia's existing Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) contract with the General Services...
- This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Sebia, Inc. for a cost per test with drop shipment of reagents. The contract has a ceiling value of $98,555.60 and an ultimate completion date of July 2, 2018. Sebia, Inc. is a global leader in automated electrophoresis technologies, providing advanced medical diagnostic equipment, reagents, consumables, and clinical testing services to federal healthcare...
- This is a $7,943.05 firm fixed-price purchase order awarded to Sebia, Inc. by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8. The contract is for the provision of specialized medical equipment, reagents, consumables, testing services, and maintenance support related to automated electrophoresis systems. This award aligns with the VA's clinical laboratory and diagnostic testing programs and enables Sebia to deliver crucial products and services to VA medical...
- This is a delivery order contract awarded by the Department of the Army Medical Command to Sebia, Inc., a for-profit organization, for immunochemistry testing services. The contract has a firm fixed price of $128,615.00 and was awarded on October 1, 2017, with a completion date of March 31, 2018. The place of performance is San Antonio, TX 78234. The contract is not designated as a set-aside. Sebia, Inc. is a global leader in automated electrophoresis, providing specialized medical equipment,...
- This federal contract, awarded by the Department of the Army Medical Command, is for the delivery of electrophoresis reagents to be used at Tripler Army Medical Center in Hawaii. The contract was awarded to Sebia, Inc., a global leader in automated electrophoresis solutions, on October 1, 2021 for a potential value of $11,089.38. The contract is a Delivery Order with a Firm Fixed Price pricing type and a completion date of September 30, 2022. Sebia, a for-profit organization, has previously...
This firm-fixed price purchase order contract was awarded by the U.S. Army Medical Command (MEDCOM) to Sebia, Inc., a global leader in automated electrophoresis technologies, for the provision of reagents, supplies, and associated equipment. The contract, valued at $230,000.00, covers a base period and 1-year option period for the delivery of critical laboratory testing consumables and trade-in of existing equipment to support pathology services at Madigan Army Medical Center. The original solicitation was issued as a sole source acquisition under simplified procedures, as Sebia's proprietary products and testing capabilities were determined to be the only compatible solution for the customer's requirements. The contract is not set-aside and reflects Sebia's competitive position in providing specialized electrophoresis systems and related clinical testing services to various federal healthcare agencies, including the Department of Veterans Affairs (VA) and Department of Defense (DoD). Sebia holds several significant Indefinite Delivery Vehicles with the VA and military commands, enabling flexible procurement of its technologies across multiple regions and medical facilities.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Base +1 yr-Renewal A1C Hemoglobin Controls-Reagents wth HGB Analyzer | W81K0220Q0242 | Department of the Army Medical Command | Special Notice 1/2 | 9/25/20, 4:23 PM | |
Base +1 yr-Renewal A1C Hemoglobin Controls-Reagents wth HGB Analyzer | W81K0220Q0242 | Department of the Army Medical Command | Award Notice 2/2 | 9/28/20, 12:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $40.0k | 6/9/22 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 11/10/21 | |
| P00003 | Funding Only Action | $95.0k | 10/28/21 | |
| P00002 | Exercise an Option | $0 | 7/15/21 | |
| P00001 | Funding Only Action | $95.0k | 11/5/20 |